Cognitive Impairment Associated with Schizophrenia: …

Administration (FDA) or European Medicines Agency (EMA) approved treatment targeting cognitive impairment associated with schizophrenia (CIAS). Treatments available for schizophrenia include typical and atypical antipsychotics, which predominantly target the positive symptoms of schizophrenia [18]. Despite the availability of antipsychotic ................
................